Clinical Trial Update: Retrospective Evaluation of Melanocortin Receptor 4 Polymorphisms in Patients With GBM Treated With Radiochemotherapy

View source ↗

Summary

This study retrospectively examined melanocortin-4 receptor polymorphisms in glioblastoma patients treated with radiochemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: University of Pisa | Conditions: Glioblastoma | Status: COMPLETED